Page 20 - Journal of Structural Heart Disease Volume 2, Issue 6

247
Meeting Abstracts
Figure 2 (#0014).
Figure 1 (#0015).
A
B
9 year old girl, presented with palpitation and progressive shortness of breath.
Underwent ICR for TOF 3 years back.
Echo showed a residual perimembranous VSD measuring 8 mm.
#0016
PERCUTANEOUS CLOSURE OF PATENT DUCTUS ARTERIOSUS – 20 YEARS EXPERIENCE OF ONE CENTER
Michal Galeczka, Jacek Bialkowski, Malgorzata Szkutnik, Roland Fiszer, Sebastian Smerdzinski
Silesian Center for Heart Diseases, Congenital Heart Defects and Pediatric Cardiology Dept., Zabrze, Silesia, Poland
Introduction: Percutaneous closure has become a method of choice in treatment of patent ductus arteriosus (PDA). Recently different types of occluders have evolved. We present our own experience in this field.
Materials and Methods: Between 1996 and 2016 840 patients (pts; 543 f; 0,3-84,5y; median 4y) had percutaneous PDA closure performed in our center. PDA A type was present in 415pts, B in 23pts, C in 60pts, D in 105pts, E in 192pts, G in 25pts, moreover, 20pts had previously ligated PDA recanalized. Reversible pulmonary hypertension (PH) was observed in 121pts (14,4%). We divided this period in double umbrella (DU) era (1996-2000), detachable coils (C) era (1996-2014) and nitinol wire mesh devices era: like Amplatzer Duct Occluder type I (ADO I) (1997-now), Amplatzer Duct Occluder type II (ADO II) (2009- now) and Amplatzer Duct Occluder type II Additional Sizes (ADO II AS) (2014-now). Application techniques of mentioned above devices were routine. In special situations another devices were used.
Results: We have applied DU in 25pts with 88% success rate (1 embo- lisation), C in 463pts with 96,8% success rate (7 embolisations), in 250 pts ADO I and like ADO I occluders with 100% success rate (ADO I in 140pts, Cera Occluder in 8pts, Cardi-o-Fix in 64pts, HeartR in 27pts, Hyperion in 11pts), ADO II in 15pts with 100% success rate and ADO II AS in 71pts with 98,6% success rate. Moreover, in type B of PDA 5 CardioSEAL/STAR ex devices and 2 ASD nitinol wire mesh occluders; in type D of PDA 3 Amplatzer Vascular Plugs type II and in 6 pts with higher PH Muscular Amplatzer VSO were used with 100% success rate. Residual shunt 24 hours after the procedure was observed in 24% of DU, 16,7% of C and no residual shunts were observed in other groups of pts.
Conclusions: PDA percutaneous closure methods have quickly devel- oped and nowadays they are not only safe and e cient but repre- senting also relatively low complication rate.
1. LV graphy showing residual VSD
2. Arterio- venous loop
4. Device posi oned at VSD
3. 12/10 ADO 1 Device
4. (cont) Device posi oned at VSD
5. Device posi oned checked
6. Device posi on confirmed
#0015
DEVICE TO THE RESCUE
Taw q Shahriar Huq
National Heart Foundation Hospital & Research Institute, Dhaka, Bangladesh
Hijazi, Z
20th Annual PICS/AICS Meeting Abstracts